<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Remdesivir Enters Clinical Trials as COVID-19 Treatment
Image Overlay - Remdesivir Enters Clinical Trials as COVID-19 Treatment

Remdesivir Enters Clinical Trials as COVID-19 Treatment

April 13, 2020

Remdesivir Enters Clinical Trials as COVID-19 Treatment

Gilead Sciences has initiated two Phase 3 clinical studies to evaluate the safety and efficacy of remdesivir in adults diagnosed with COVID-19 following the FDA’s rapid review and acceptance of Gilead’s IND filing. Enrollment of the clinical trial began in March — at present, 1000 participants will be entered into the trial. Yourway is committed to advancing trials and has full DTP capacity, which is particularly relevant given the stay-home-orders in place across countries and states.

Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?